# Phio Pharmaceuticals Corp.: Form 8-K, filed Nov 20, 2019

- Company: [Phio Pharmaceuticals Corp.](/companies/phio.md) (CIK 1533040)
- Form: 8-K
- Filed: 2019-11-20
- Accepted by EDGAR: Nov 19, 2019, 21:29 ET
- Period: 2019-11-19
- Accession: 0001683168-19-003762
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1533040/000168316819003762/phio_8k-112019.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1533040/000168316819003762/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1533040/000168316819003762/phio_8k-112019.htm

Filed Nov 20, 2019.
Source: SEC EDGAR, the filing index for accession 0001683168-19-003762. Last ingested by Listed: Nov 12, 2026, 20:44 ET. No prices; not investment advice.
